Bavarian Nordic’s cancer vaccine CV301 paired with Imfinzi, its third PD-1/L1 combo

7 years ago

by David Miller

969 Views

Written by David Miller

Following through on its strategy of showing CV301 could work in multiple tumor types, Bavarian Nordic has agreed to test the cancer vaccine in combination with AstraZeneca’s Imfinzi plus chemo in patients with metastatic colorectal or pancreatic cancers.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!